Support for Research

Research in hematology is critical to improving our understanding of diseases, clinical practice, and overall patient care. Support for research in hematology is a priority for EHA, including in European Affairs. For years, EHA together with other medical societies and patient organizations has been advocating for EU-level strategies or collaboration around topics that are now central to the EU’s new policies: accessibility and affordability; patient-centric, unmet needs based development of medicines; dedicated regulatory and data frameworks for personalized medicine and rare diseases. Find EHA’s position papers here.

List of relevant EU-funded calls for Hematology:

European Partnership on rare diseases (deadline: 19 September 2023)
Personalised prevention of non-communicable diseases - addressing areas of unmet needs using multiple data sources (deadline: 19 September 2023 for stage 1)
Innovative non-animal human-based tools and strategies for biomedical research (deadline: 19 September 2023 for stage 1)
Comparative effectiveness research for healthcare interventions in areas of high public health need (deadline: 19 September 2023 for stage 1)
Tackling high-burden for patients, under-researched medical conditions (deadline: 19 September 2023 for stage 1)
ERC Proof of Concept Grants (deadline: 21 September 2023)
European Researchers’ Night and Researchers at Schools 2024-2025 (deadline: 25 October 2023)
MSCA Doctoral Networks 2023 (deadline: 28 November 2023)
Capacity building on Intellectual Property (IP) management to support open science (deadline: 12 March 2024)
Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs) (deadline: 11 April 2024)